Anxiety disorder, Tourette syndrome added to medical marijuana approved conditions
By Brett Sholtis/Transforming Health
Salesperson Cheri McFarland works on a sales computer in front of displayed marijuana products at Beyond/Hello, Center City Philadelphia’s first medical marijuana dispensary on Jan. 24, 2019. (AP Photo/Matt Slocum)
The Pennsylvania Department of Health has added anxiety disorders and Tourette syndrome to the list of medical conditions approved for receiving medical marijuana.
Health Secretary Dr. Rachel Levine said she made the decision based on the Medical Marijuana Advisory Board’s recommendation as well as a review of medical research. It’s a decision she didn’t make lightly, she said.
“For both conditions, medical marijuana is not first-line treatment and should not replace traditional therapies, but should be used in conjunction with them, when recommended by a physician,” Levine said.
Patients with anxiety disorders should pursue counseling and therapy to manage their illness, Levine noted. Research indicates medical marijuana with low THC and high CBD content are more effective for treatment of anxiety disorders than other forms of medical marijuana. Levine noted it is recommended for short-term use.
Medical marijuana is not recommended for children, adolescents or pregnant women.